Adverse Drug Reaction Monitoring Centre, NIPER Hajipur

The Pharmacovigilance Programme of India (PvPI) is an initiative by the Central Drugs Standard Control Organization (CDSCO) in collaboration with the Indian Pharmacopoeia Commission (IPC), operating under the Ministry of Health and Family Welfare, Government of India. The program aims to monitor adverse drug reactions (ADRs) and ensure the safety of medicines in the country, thereby improving patient safety. NIPER Hajipur is one of the recognized centers for reporting adverse drug reactions associated with medicines in Bihar to the Indian Pharmacopeia Commission, Ghaziabad (IPC).

NIPER Hajipur AMC has actively participated in this program since Dec 2021 and has reported numerous ADRs until 2023. It is also among the top-five performing centres in India. NIPER Hajipur AMC is also a recognised training center for educational and training programs for Pharmacovigilance activities in Bihar State. NIPER Hajipur has conducted various training programs to create awareness of drug-related ADRs. Recently, it celebrated the 3rd National Pharmacovigilance Week from 17th to 23rd September 2023. The program aimed to boost public confidence in Pharmacovigilance for adverse drug reactions (ADRs) reporting in collaboration with IPC Ghaziabad and other collaborative clinical facilities. This training program was attended by more than 250 attendees.